综合性分析显示SRD5A2是PPCP诱导的前列腺癌免疫微环境调节的中心调解者
1Department of Urology, Santai Hospital Affiliated to North Sichuan Medical College, Mianyang, 621100, Sichuan, China.
Discover oncology
|November 21, 2025
概括
药品和个人护理产品 (PPCPs) 可能通过影响关键基因促进前列腺癌 (PCa). 这项研究确定了24个PPCP和4个基因,包括SRD5A2,与PCa进展和免疫逃避有关.
科学领域:
- 环境健康 环境健康
- 在瘤学瘤学.
- 毒理学 毒理学 毒理学
背景情况:
- 药品和个人护理产品 (PPCP) 是新兴的微污染物.
- 它们在前列腺癌 (PCa) 发展中的作用基本上是未知的.
- 这项研究研究了PPCP对PCa进展的影响.
研究的目的:
- 阐明PPCP影响PCa的机制.
- 为了确定参与PPCP诱导的PCa的关键基因.
- 探索PPCP与瘤免疫微环境 (TIME) 之间的关系.
主要方法:
- 网络毒理学方法用于识别PCa.中的PPCP相关基因.
- 生物信息学分析用于基因定位和机制阐明.
- 分子对接以评估PPCP与基因的结合亲和力.
主要成果:
- 在49个PPCP中确定了24个可能促进PCa的PPCP.
- 网络毒理学发现156个PPCP-PCa相关基因.
- 确定了四个预后基因 (F2,SRD5A2,NEK2,HGFAC),其中SRD5A2显示了与TIME的最高结合亲和力和相关性.
结论:
- 在PPCP诱导的PCa进展中,F2,SRD5A2,NEK2和HGFAC是至关重要的.
- 通过降低SRD5A2的调节,PPCPs可能会促进PCa,从而破坏TIME恒温.
- 这种干扰导致免疫逃避和加速瘤进展.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
709
08:05Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
1.1K
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
